Ftse Mib
34.429,07
-0,05%
DAX
18.467,04
-0,25%
S&P 500
5.210,96
-0,47%
NASDAQ
16.563,55
-1,04%
Bitcoin
67.338,81
-1,48%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ T2 Biosystems Inc (TTOO) T2 Biosystems Inc (TTOO) Notizie

TTOO

T2 Biosystems (TTOO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTOO
DataOraFonteTitoloSimboloCompagnia
25/05/202403:04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TTOOT2 Biosystems Inc
22/05/202422:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
22/05/202415:00GlobeNewswire Inc.T2 Biosystems Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:TTOOT2 Biosystems Inc
17/05/202422:05GlobeNewswire Inc.T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:TTOOT2 Biosystems Inc
15/05/202413:00GlobeNewswire Inc.T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:TTOOT2 Biosystems Inc
14/05/202423:00GlobeNewswire Inc.T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common StockNASDAQ:TTOOT2 Biosystems Inc
14/05/202422:55Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:TTOOT2 Biosystems Inc
14/05/202401:21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TTOOT2 Biosystems Inc
14/05/202400:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
07/05/202415:00GlobeNewswire Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseNASDAQ:TTOOT2 Biosystems Inc
06/05/202423:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
06/05/202423:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTOOT2 Biosystems Inc
06/05/202422:34GlobeNewswire Inc.T2 Biosystems Announces First Quarter 2024 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
06/05/202422:34GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Middle East DistributorNASDAQ:TTOOT2 Biosystems Inc
06/05/202422:29GlobeNewswire Inc.T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
24/04/202415:00GlobeNewswire Inc.T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024NASDAQ:TTOOT2 Biosystems Inc
11/04/202422:05GlobeNewswire Inc.T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityNASDAQ:TTOOT2 Biosystems Inc
28/03/202414:00GlobeNewswire Inc.T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.NASDAQ:TTOOT2 Biosystems Inc
20/03/202412:30GlobeNewswire Inc.T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
19/03/202414:00GlobeNewswire Inc.T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
18/03/202414:00GlobeNewswire Inc.T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance PanelNASDAQ:TTOOT2 Biosystems Inc
12/03/202414:00GlobeNewswire Inc.T2 Biosystems Receives Extension to Comply with Nasdaq Listing RequirementNASDAQ:TTOOT2 Biosystems Inc
04/03/202422:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:49Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:06GlobeNewswire Inc.T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:04GlobeNewswire Inc.T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
15/02/202422:02GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and AsiaNASDAQ:TTOOT2 Biosystems Inc
14/02/202402:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TTOOT2 Biosystems Inc
12/02/202415:00GlobeNewswire Inc.T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria PanelNASDAQ:TTOOT2 Biosystems Inc
07/02/202422:05GlobeNewswire Inc.T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024NASDAQ:TTOOT2 Biosystems Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTOO

La tua Cronologia

TSXV
GMER.P
Mithrandir Capital
COIN
RFDETH
REFUND
BMF
DAPK55
DAPK55 - Maio 2055
COIN
GEEQUSD
Geeq
LSE
DSUS
Am Ust10y-2xinv
LSE
0QNS
Curatis
BIT
EUCO
SSgA SPDR ETFs EUROPE I ...
TSXV
SKRR
SKRR Exploration
BIT
ELG
Eligo
NYSE
UPS
United Parcel Service
TG
CVG
CSPC Pharmaceutical
LSE
10NG
Tsb Bank
ASX
DOWSO2
LSE
CBOX
Cake Box
TSX
PYF.U
Purpose Premium Yield
CSE
DYME
DionyMed Brands
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network